One week 17 companies compete for IPO, raising a total of1800 million! After 90, the chairman appeared.

At this week's IPO meeting of 17 companies, the total amount of funds raised reached1800 million yuan. 1February 12, science and technology innovation board and Growth Enterprise Market welcomed four companies to attend the meeting, among which photovoltaic silicon wafer company Ke Mei successfully attended the meeting, raising 5 billion yuan, ranking first among the companies attending the meeting this week.

He Jiang Paper, which will land on the main board of Shenzhen this Thursday (12, 15), is a large modern manufacturing enterprise integrating R&D, specialty paper and papermaking equipment production and sales. It is worth noting that Jiang Boen, one of the controlling shareholders and actual controllers of He Jiang Paper, was born in 1993 and concurrently serves as the chairman and general manager of the company. The data shows that Jiang Boen is about to become the youngest chairman of a listed company in the paper industry.

Photovoltaic silicon wafer enterprises raised 5 billion yuan.

Ke Mei Co., Ltd., founded on 20 17, is a professional manufacturer of silicon rods/ingots and wafers in the upstream of photovoltaic industry chain. At present, we are mainly engaged in the research and development, production and sales of monocrystalline silicon rods and wafers, as well as the entrusted processing services of monocrystalline silicon wafers.

20 19, Ke Mei shares engaged in research and development, production and sales of polysilicon ingots and silicon wafers. Since 2020, in order to comply with the technological development trend of single crystal replacing polycrystalline products in photovoltaic industry, Ke Mei decided to implement the business strategy of focusing on single crystal technology and perfecting the single crystal industrial chain. In the second half of 2020, the polycrystalline business was completely stopped, and the industrial chain was improved through major asset restructuring, realizing a comprehensive strategic transformation from polycrystalline ingot and polycrystalline slicing business to single crystal wire drawing and slicing business.

The performance shows that Ke Mei's transformation from polysilicon to monocrystalline silicon is quite successful, and its performance has turned losses into profits. From 2020 to the first three quarters of 2022, Ke Mei achieved operating income of 867 million yuan, 3,665.438+0.2 billion yuan and 8.87 billion yuan; The net profit was-34,686,800 yuan, 20 1 billion yuan and1.01.90 million yuan respectively.

On the customer side, Ke Mei has established long-term and stable cooperative relations with leading enterprises in photovoltaic industry at home and abroad, such as Zheng Tai Group, Tongwei Group, Aixu Group, Hanwha Group, Trina Solar and Runyang Group. As of March 3, 2022, Ke Mei Co., Ltd. has signed and is implementing a long list of silicon wafer sales from June 3, 2022 to June 2, 2024, totaling about 8.08 billion wafers, which has covered all the current silicon wafer production capacity of the company.

In terms of shareholding structure, the controlling shareholder of Ke Mei is Huantai Development, which directly holds 60.96% of the company's shares; Actual controllers The actual controllers of the company are Wang Lubao, Wang Lubao, Wang Lubao, Wang Lubao and Wang Lubao. In terms of shareholders, Sinopec Capital holds 7.85% of the shares of Ke Mei, making it the second largest external shareholder of the company; Zheng Tai New Energy holds a 3.5% stake in Ke Mei; In addition, after the penetration of shareholders, Huaneng Investment, Guodian Investment Fund, China Merchants Capital, Jianxin Investment and many other well-known industrial funds also hold shares. The IPO of Ke Mei shares plans to raise 5 billion yuan, which will be invested in the third phase of the 20GW single crystal rod drawing project of Ke Mei Silicon Energy Co., Ltd. and supplementary working capital.

In addition, science and technology innovation board Xintong Pharmaceutical Co., Ltd. suspended trading on the same day. ICT Medicine is an innovative drug research and development enterprise, focusing on epilepsy, hepatitis B, liver cancer and other diseases. At present, the company has 8 main products under research, of which 5 products are in clinical trial and approval stage and 3 products are in preclinical stage. It is worth noting that ICT medicine has not yet achieved profitability. The IPO of Xintong Pharmaceutical intends to raise 654.38+0.28 billion yuan, of which 900 million yuan will be used for "new drug research and development project", 654.38+0.8 billion yuan for "innovative drug industrialization production base construction project" and 200 million yuan for "supplementary liquidity project".

Chairman of the post-90 s

He Jiang Paper, which will be listed on the main board of Shenzhen Stock Exchange this Thursday (65438+February 65438+May), is a large-scale modern manufacturing enterprise integrating R&D, specialty paper and papermaking equipment production and sales. Its main products include four categories: information and business communication paper, special printing paper, food packaging and release paper, paper-making equipment and technical services.

He Jiang Paper has three papermaking production bases and one papermaking equipment production base in Wuzhi County, Henan Province and Qihe County, Shandong Province, with a total of 14 paper machine production line and more than 30 coating processing lines, with an annual production capacity of over 600,000 tons.

In terms of performance, in the first three quarters from 20 19 to 20021.51100 million yuan, 3.387 billion yuan and 3.201100 million yuan respectively, and the net profit was1. In this IPO sprint, He Jiang Paper plans to land on the main board of Shenzhen Stock Exchange to raise 65.438+97.5 billion yuan for the deep processing project of special paper with an annual output of 200,000 tons, the deep processing project of special paper with an annual output of 6.5438+02,000 tons, and to supplement the working capital.

According to the prospectus, Jiang, the original founder of the paper industry, died on July 3, 20654381. According to his will, all the 46,300,600 shares of He Jiang Paper owned by him were personally inherited by Jiang Boen, and Jiang Boen obtained 5 1.445 1% shares of He Jiang Paper held by Jiang Fengwei through will inheritance.

Subsequently, after several rounds of equity changes, as of the signing date of the prospectus, the controlling shareholders and actual controllers of He Jiang Paper are Jiang Boen and Ceng Yun, and Ceng Yun and Mr. Jiang Boen are mother and son. Jiang Boen directly holds 33.99% of the shares of He Jiang Paper, Ceng Yun directly holds 65,438+04.59% of the shares of the company, Jiang Boen and Ceng Yun indirectly hold 0.66% and 0.48% of the shares of the company respectively through Jiang Wei Partnership, and Jiang Boen and Ceng Yun jointly hold 49.72% of the shares of the company directly and indirectly, and jointly own the control of the company.

According to the resume, Jiang Boen was born in 1993, and served as assistant to the general manager of He Jiang Paper from April 20 17 to April 20 18. 2065 438+08-2065 438+09 Executive Deputy General Manager of Any Jiang Paper Industry; 2065438+July 2009 Chairman and General Manager of any Jiang Paper. If He Jiang Paper successfully passes the meeting, Jiang Boen will also become the youngest chairman of listed companies in the A-share paper industry.